Results 221 to 230 of about 1,805,294 (373)

Research of affordability to essential medicines for coronary heart disease in Ukraine. [PDF]

J Pharm Policy Pract
Bilousova N, Tkachenko N, Kozhuharyova N, Dolzhenko M.   +3 more
europepmc   +1 more source

Corrigendum to “The “L-Sandwich” Strategy for True Coronary Bifurcation Lesions: A Randomized Clinical Trial”

Journal of Interventional Cardiology
Quan Guo, Liang Peng, Lixin Rao, Cao Ma, Kang Zhao, Zhenzhou Zhao, Haiyu Tang, Muwei Li   +7 more
doaj   +1 more source

Coronary heart disease with pulmonary embolism: A case report. [PDF]

World J Cardiol
Xu JQ, Jiang MX, Wang F, Yang KQ, Xu YJ, Wang YJ, Dong SJ.   +6 more
europepmc   +1 more source

Predictors and morphological properties of culprit healed plaques in patients with angina pectoris

Clinical Cardiology, Volume 45, Issue 12, Page 1199-1210, December 2022., 2022
Abstract Background Plaque healing may serve a vital function in the natural progression of atherosclerotic disease. This study sought to investigate predictors and morphological characteristics of healed plaque (HP) among angina pectoris (AP) patients.
Hongying Yao, Qianyun Guo, Yujing Cheng, Tianyu Zhu, Qian Ma, Yujie Zhou   +5 more
wiley   +1 more source

Role of interleukins in the pathogenesis of coronary heart disease: A literature review. [PDF]

World J Cardiol
Rafaqat S, Azam A, Hafeez R, Faseeh H, Tariq M, Asif M, Arshad A, Noshair I.   +7 more
europepmc   +1 more source

Survival benefit of overweight patients undergoing MitraClip® procedure in comparison to normal‐weight patients

Clinical Cardiology, Volume 45, Issue 12, Page 1236-1245, December 2022., 2022
Long‐term survival stratified for weight classes illustrated by Hazard plot for patients treated with MitraClip® implantation stratified for weight classes. Association of weight class compared to normal‐weight with long‐term survival (adjusted for Logistic EuroScore).
Karsten Keller, Martin Geyer, Lukas Hobohm, Alexander R. Tamm, Felix Kreidel, Tobias F. Ruf, Michaela Hell, Volker H. Schmitt, Kevin Bachmann, Sonja Born, Eberhard Schulz, Thomas Münzel, Ralph S. von Bardeleben   +12 more
wiley   +1 more source

Effect of thyroid stimulating hormone on the prognosis of coronary heart disease. [PDF]

Front Endocrinol (Lausanne)
Ding N, Hua R, Guo H, Xu Y, Yuan Z, Wu Y, Li T.   +6 more
europepmc   +1 more source

Adherence with cardiovascular medications and the outcomes in patients with coronary arterial disease: “Real‐world” evidence

Clinical Cardiology, Volume 45, Issue 12, Page 1220-1228, December 2022., 2022
Abstract Background Cardiovascular medications are vital for the secondary prevention of coronary arterial disease (CAD). However, the effect of cardiovascular medication may depend on the optimal adherence of the patients. This meta‐analysis aims to determine the magnitude of adherence to vascular medications that influences the absolute and relative ...
Chen Chen, Xiaoqing Li, Yuhao Su, Zhigang You, Rong Wan, Kui Hong   +5 more
wiley   +1 more source

Psychosocial interventions for smoking cessation in people with coronary heart disease. [PDF]

Cochrane Database Syst Rev
Righi L, Barth J, Baicus C, Critchley JA, Daha I, McCarey M, von Elm E.   +6 more
europepmc   +1 more source

Day‐to‐day fasting plasma glucose variability on the short‐term prognosis of ST‐segment elevation myocardial infarction: A retrospective cohort study

Clinical Cardiology, Volume 45, Issue 12, Page 1246-1254, December 2022., 2022
Abstract Background and Hypothesis Glycemic variability in one fact that explain the differences in cardiovascular outcomes. The short‐term fasting plasma glucose (FPG) variability may have an on major adverse cardiovascular events (MACE) in type 2 diabetes mellitus (T2DM) patients with ST‐segment elevation myocardial infarction (STEMI).
Ming Yi, Qing Cao, Wen‐hui Tang, Qiang Liu, Xiao Ke   +4 more
wiley   +1 more source